Craniopharyngioma in adults

Craniopharyngiomas are slow growing benign tumors of the sellar and parasellar region with an overall incidence rate of approximately 1.3 per million. During adulthood there is a peak incidence between 40 and 44 years. There are two histopathological types, the adamantinomatous and the papillary typ...

Full description

Bibliographic Details
Main Authors: Flavius eZoicas, Christof eSchöfl
Format: Article
Language:English
Published: Frontiers Media S.A. 2012-03-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fendo.2012.00046/full
id doaj-f650830a0a7946edbcf43c45948202ba
record_format Article
spelling doaj-f650830a0a7946edbcf43c45948202ba2020-11-24T22:19:27ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922012-03-01310.3389/fendo.2012.0004624694Craniopharyngioma in adultsFlavius eZoicas0Christof eSchöfl1Friedrich-Alexander-University Erlangen-NurembergFriedrich-Alexander-University Erlangen-NurembergCraniopharyngiomas are slow growing benign tumors of the sellar and parasellar region with an overall incidence rate of approximately 1.3 per million. During adulthood there is a peak incidence between 40 and 44 years. There are two histopathological types, the adamantinomatous and the papillary type. The later type occurs almost exclusively in adult patients. The presenting symptoms develop over years and display a wide spectrum comprising visual, endocrine, hypothalamic, neurological and neuropsychological manifestations. Currently, the main treatment option consists in surgical excision followed by radiation therapy in case of residual tumor. Whether gross total or partial resection should be preferred has to be balanced on an individual basis considering the extent of the tumor (e.g. hypothalamic invasion). Although the overall long-term survival is good it is often associated with substantial morbidity. Preexisting disorders are often permanent or even exacerbated by treatment. Endocrine disturbances need careful replacement and metabolic sequelae should be effectively treated. Regular follow-up by a multidisciplinary team is a prerequisite for optimal outcome of these patients.http://journal.frontiersin.org/Journal/10.3389/fendo.2012.00046/fullAdultCraniopharyngiomadiagnosisprognosisTreatmentcomplications
collection DOAJ
language English
format Article
sources DOAJ
author Flavius eZoicas
Christof eSchöfl
spellingShingle Flavius eZoicas
Christof eSchöfl
Craniopharyngioma in adults
Frontiers in Endocrinology
Adult
Craniopharyngioma
diagnosis
prognosis
Treatment
complications
author_facet Flavius eZoicas
Christof eSchöfl
author_sort Flavius eZoicas
title Craniopharyngioma in adults
title_short Craniopharyngioma in adults
title_full Craniopharyngioma in adults
title_fullStr Craniopharyngioma in adults
title_full_unstemmed Craniopharyngioma in adults
title_sort craniopharyngioma in adults
publisher Frontiers Media S.A.
series Frontiers in Endocrinology
issn 1664-2392
publishDate 2012-03-01
description Craniopharyngiomas are slow growing benign tumors of the sellar and parasellar region with an overall incidence rate of approximately 1.3 per million. During adulthood there is a peak incidence between 40 and 44 years. There are two histopathological types, the adamantinomatous and the papillary type. The later type occurs almost exclusively in adult patients. The presenting symptoms develop over years and display a wide spectrum comprising visual, endocrine, hypothalamic, neurological and neuropsychological manifestations. Currently, the main treatment option consists in surgical excision followed by radiation therapy in case of residual tumor. Whether gross total or partial resection should be preferred has to be balanced on an individual basis considering the extent of the tumor (e.g. hypothalamic invasion). Although the overall long-term survival is good it is often associated with substantial morbidity. Preexisting disorders are often permanent or even exacerbated by treatment. Endocrine disturbances need careful replacement and metabolic sequelae should be effectively treated. Regular follow-up by a multidisciplinary team is a prerequisite for optimal outcome of these patients.
topic Adult
Craniopharyngioma
diagnosis
prognosis
Treatment
complications
url http://journal.frontiersin.org/Journal/10.3389/fendo.2012.00046/full
work_keys_str_mv AT flaviusezoicas craniopharyngiomainadults
AT christofeschofl craniopharyngiomainadults
_version_ 1725779166092066816